Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors.

PHASE1CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 18, 2021

Primary Completion Date

October 24, 2023

Study Completion Date

October 24, 2023

Conditions
Non-Small Cell Lung CancerSquamous Cell Carcinoma of the Head and NeckOvarian Cancer
Interventions
BIOLOGICAL

PF-07257876

CD47-PDL-1 bispecific antibody

Trial Locations (43)

15213

Magee-Womens Hospital of UPMC, Pittsburgh

15232

UPMC Hillman Cancer Center, Pittsburgh

UPMC Shadyside Hospital, Pittsburgh

16505

UPMC Hillman Cancer Center Erie, Erie

17011

UPMC Hillman Cancer Center - Camp Hill, Camp Hill

17015

UPMC Hillman Cancer Center - Carlisle, Carlisle

17050

UPMC Pinnacle - Ortenzio Cancer Center (OCC), Mechanicsburg

17109

UPMC Pinnacle - Community Osteopathic / Medical Sciences Pavilion (MSP), Harrisburg

17408

UPMC Memorial, York

22031

Virginia Cancer Specialists, Fairfax

27710

Duke Cancer Institute, Durham

28009

Hospital General Universitario Gregorio Marañon, Madrid

28041

Hospital Universitario 12 de Octubre, Madrid

32224

Mayo Clinic Jacksonville, Jacksonville

46010

Hospital Clinico de Valencia, Valencia

55905

Mayo Clinic Rochester, Rochester

63031

Siteman Cancer Center-North County, Florissant

63110

Barnes-Jewish Hospital, St Louis

Washington University School of Medicine, St Louis

Washington University, St Louis

63129

Siteman Cancer Center - South County, St Louis

63141

Siteman Cancer Center - West County, Creve Coeur

63376

Siteman Cancer Center - St Peters, City of Saint Peters

72703

Highlands Oncology Group, Fayetteville

72758

Highlands Oncology Group, Rogers

72762

Highlands Oncology Group, Springdale

85054

Mayo Clinic Hospital, Phoenix

85259

Mayo Clinic, Scottsdale

90025

The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles

90033

Keck Hospital of USC, Los Angeles

Keck School of Medicine of USC, Los Angeles

LAC+USC Medical Center, Los Angeles

USC/Norris Comprehensive Cancer Center, Los Angeles

90404

The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate (Emergency Back-Up Only), Santa Monica

91105

Keck Hospital of USC Pasadena, Pasadena

92618

Hoag Hospital Irvine, Irvine

92663

Hoag Memorial Hospital Presbyterian, Newport Beach

98109

Seattle Cancer Care Alliance, Seattle

07601

Hackensack University Medical Center, Hackensack

John Theurer Cancer Center at Hackensack University Medical Center, Hackensack

02903

Rhode Island Hospital, Providence

02906

The Miriam Hospital, Providence

08035

Hospital Universitari Vall d'Hebron, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04881045 - Study to Test the Safety and Tolerability of PF-07257876 in Participants With Selected Advanced Tumors. | Biotech Hunter | Biotech Hunter